NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings

8-K - Harmony Biosciences Holdings, Inc. - 5.02 / 7.01 / 9.01

Filed: 2026-04-14 AccNo: 0001104659-26-042886 Size: 635 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
发布时间04/14 12:15 UTC
首次发现04/14 12:16 UTC
热度107.3
重要度84
情绪-0.02

站内整理正文

优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 889 字符

Form 8-K - Current report: SEC Accession No. 0001104659-26-042886

Filing Date: 2026-04-14

Accepted: 2026-04-14 08:15:10

Documents: 15

Period of Report: 2026-04-14

Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Harmony Biosciences Holdings, Inc. (Filer) CIK : 0001802665 (see all company filings) EIN. : 822279923 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 26859234 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | hrmy-20260414x8k.htm iXBRL | 8-K

2 | EX-10.1 | hrmy-20260414xex10d1.htm | EX-10.1

3 | EX-10.2 | hrmy-20260414xex10d2.htm | EX-10.2

4 | EX-99.1 | hrmy-20260414xex99d1.htm | EX-99.1